{"id":1012263,"date":"2026-10-21T16:42:45","date_gmt":"2026-10-21T20:42:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/"},"modified":"2026-10-21T16:42:45","modified_gmt":"2026-10-21T20:42:45","slug":"cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/","title":{"rendered":"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>FREMONT, Calif., Oct.  21, 2026  (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced that it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The company\u2019s management will also host a conference call to discuss its results, business developments and outlook beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time on the same day.<\/p>\n<p>A live audio webcast of the call will be available on the \u201cInvestors\u201d section of the company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6a-IhJimS81g3QstY2Il4G5uN5OGv3WbqmEa-RGRX4cyc0DLTL7eLz2eVxaCtO1n6FFq8HaSd6g0AiwhDibuwzeao1qgg7e-t3S9GjDOCdhU1ikrgH8WG3rIgpF4fdqbOpxsnwHuWzNIbBfTDAjlWUugFCUSzZGDte-9Ck38Gun9fcgDS1qu-n9kH8qewxPmEGb0EJgN2xYLtH9_KJIXN19MStmox61Hx_wg32AYtJb37encj790ZXA1t0Dx3ij3ra6PeASsKXOklXTISHyvyXwpI1MoQ74oYKLOindXoPT3MEkjA88lj-3Em6DO8C6Caa5wsGBHnGrRPZQgDXWh3CsJdMkJBbh6-LvZZquigrFc26PneDiSTb3BYMqJk9OLtY9DI9OzzTspyJ57ZuHIgSJvzPti58dQWzmnhZt8TiwNSSOeAo01-6qj-8_AxLj_\" rel=\"nofollow\" target=\"_blank\">investors.cytekbio.com<\/a>.<\/p>\n<p>\n        <strong>About Cytek Biosciences, Inc.<\/strong><br \/>\n        <br \/>Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP\u00ae) technology. Cytek\u2019s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek\u2019s platform includes: its core FSP instruments, the Cytek Aurora\u2122, Northern Lights\u2122, Cytek Aurora\u2122 CS, Cytek Aurora\u2122 Evo, and Cytek Borealis\u2122 systems; the Cytek Orion\u2122 reagent cocktail preparation system; the Enhanced Small Particle\u2122 (ESP\u2122) detection technology; the flow cytometers and imaging products under the Amnis\u00ae and Guava\u00ae brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K5UWs8UHFIJzxkdeSznLIH5vNRooW2DXyVGHjWV2cRYOVlSqB2qA25GlPFyV-LCRuaVU2_knswSSo1rZCtFEUjI-d4TyK4AKzfnDnfCx_-4yCX35jYlsf_p7PyZzWa-JManOr433mDjbsTfsV4aJiCKV74Xe3uLTR44rfh5fwr4b9-NrdOFl7BiJP6TXE7Kvw-oUKCZ2TGBpmwv7aMwLavkMABdwAEVGhQ1fYNpE7aeQR1R6XMv6B6aHNfj2K-JL2nopnxmkuAqOCdL3pylYnLHRyuGmW5G_E41-AHqQiAmsr1lY0r3dvttP2XunfIxzaz74cEiSwuIiHp0xVF7yNBX4u49gSFW9ctLWcXiUDxsZZs5K7Tev3y1VpEf73zI1PoK9bGfKfuvLh_DGcbSRdXX5vMF6vBS5ItYxci5sUKpOkBlN42Z9Orc0Nxw3S987\" rel=\"nofollow\" target=\"_blank\">www.cytekbio.com.<\/a><\/p>\n<p>Cytek\u2019s products are for research use only and not for use in diagnostic procedures (other than Cytek\u2019s Northern Lights-CLC system and certain reagents, which are available for clinical use only in China and the European Union).<\/p>\n<p>Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Cytek Borealis, Northern Lights, Enhanced Small Particle, ESP, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.<\/p>\n<p>In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X account as channels of distribution for information about the company, its products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Certain information disseminated through these channels may be material to investors, and Cytek may use these channels to disseminate such information in accordance with Regulation FD and other applicable disclosure requirements. Therefore, investors should monitor Cytek\u2019s website, LinkedIn page, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yeMTadSIpg6ZB_3Yq5YtTVXv3nUUldp8z6WYXBCY-_Xj3Veeo-D01sXauFYG7mtpjw3PdDuL7tF6p0g7sYxzOfplLcTbzyfRVZp5T5TVd4v1YJIjYpleiHZnxmyemG1HcqYdHYxy_Y2Y0Al35zDErGFg5Qdhie1K0rmquOCHCrEkExg0OTHa_p6P-WmLWDMQ3XorvM7RUQWDTqg2QyWl5Z6Cvcx25motJt83Z2eGn8jPP0Kw7WDega1zco0CtRN_bUGuGPpHwKBm9xNgvx28O5dHisiagWfuEB9HMnvHbwMaHEVNqTOyke-wi7RqIdAh2YCvPEAgM16Es8xpzMkzpQcZQqg3Sspm98vnd6hx-_kShmq_uKnxT_VIQk4jHHGR8_ovqdghynwnzdEyf_xfZPqs-Q2s9fF4mZ57NTHz77A=\" rel=\"nofollow\" target=\"_blank\">X account<\/a> in addition to following its SEC filings, news releases, public conference calls and webcasts.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Stephanie Olsen<br \/>Lages &amp; Associates<br \/>(949) 453-8080<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yeapNAro3UeABaWlOi1lP9fpjoUJw5jMDanctGADXLmrMtf_lvFX4aewmuFyRrC9EEVSpvexeBzZl3t1oDTSCd-qz0gV4czg-uq4mKca11U=\" rel=\"nofollow\" target=\"_blank\">stephanie@lages.com<\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Mark Meehan<br \/>Cytek Biosciences<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZM83HlVXaBGs6YzKWjsjOdUycohv0PnvsD8q66SftBsAXB366hzkFiC38fALLuP4nYDcBmHf4DjplLPGXIXfYFZIcQ5ydOmJPRM6mhnhLuE=\" rel=\"nofollow\" target=\"_blank\">mmeehan@cytekbio.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2Y0YmM2ODktMGE5MS00ZThiLWIxMzEtMTFmZTI0YzlhOWNlLTExMDczNTctMjAyNi0xMC0yMS1lbg==\/tiny\/Cytek-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FREMONT, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced that it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The company\u2019s management will also host a conference call to discuss its results, business developments and outlook beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time on the same day. A live audio webcast of the call will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com. About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1012263","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FREMONT, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced that it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The company\u2019s management will also host a conference call to discuss its results, business developments and outlook beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time on the same day. A live audio webcast of the call will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com. About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity &hellip; Continue reading &quot;Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-21T20:42:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026\",\"datePublished\":\"2026-10-21T20:42:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/\"},\"wordCount\":454,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/\",\"name\":\"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=\",\"datePublished\":\"2026-10-21T20:42:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/","og_locale":"en_US","og_type":"article","og_title":"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","og_description":"FREMONT, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced that it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The company\u2019s management will also host a conference call to discuss its results, business developments and outlook beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time on the same day. A live audio webcast of the call will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com. About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity &hellip; Continue reading \"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-21T20:42:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026","datePublished":"2026-10-21T20:42:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/"},"wordCount":454,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/","name":"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=","datePublished":"2026-10-21T20:42:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTkzOSM3OTA3MzczIzIwOTU3ODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-third-quarter-2026-financial-results-on-november-4-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1012263"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012263\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1012263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1012263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1012263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}